Outer membrane inflammatory protein A, a new virulence factor involved in the pathogenesis of Helicobacter pylori

Molecular Biology Reports

Volumn 41, Issue 12, 2014, Pages 7807-7814

  Zhang, Jinyong ^a   Qian, Jiajun ^a   Zhang, Xiaoli ^a   Zou, Quanming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Biological significance; Helicobacter pylori; Outer membrane inflammatory protein A; Signal transduction

Indexed keywords

INTERLEUKIN 8; OIPA PROTEIN, HELICOBACTER PYLORI; OUTER MEMBRANE PROTEIN; VIRULENCE FACTOR;

GENETIC POLYMORPHISM; GENETICS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PROGNOSIS;

BACTERIAL OUTER MEMBRANE PROTEINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-8; POLYMORPHISM, GENETIC; PROGNOSIS; VIRULENCE FACTORS;

EID: 84939897878     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3673-9     Document Type: Article

References (50)

1. Hatakeyama M, Brzozowski T (2006) Pathogenesis of Helicobacter pylori infection. Helicobacter 11(Suppl 1):14–20
2. Penta R, De Falco M, Iaquinto G, De Luca A (2005) Helicobacter pylori and gastric epithelial cells: from gastritis to cancer. J Exp Clin Cancer Res 24(3):337–345
3. Yamaoka Y, Kikuchi S, el-Zimaity HM, Gutierrez O, Osato, Graham DY (2002) Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology 123(2):414–424
4. Hussein NR, Argent RH, Marx CK, Patel SR, Robinson K, Atherton JC (2010) Helicobacter pylori dupA is polymorphic, and its active form induces proinflammatory cytokine secretion by mononuclear cells. J Infect Dis 202(2):261–269
5. Gong M, Ling SS, Lui SY, Yeoh KG, Ho B (2010) Helicobacter pylori gamma-glutamyl transpeptidase is a pathogenic factor in the development of peptic ulcer disease. Gastroenterology 139(2):564–573
6. Senkovich OA, Yin J, Ekshyyan V, Conant C, Traylor J, Adegboyega P, McGee DJ, Rhoads RE, Slepenkov S, Testerman TL (2011) Helicobacter pylori AlpA and AlpB bind host laminin and influence gastric inflammation in gerbils. Infect Immun 79(8):3106–3116
7. Yamaoka Y, Kwon DH, Graham DY (2000) A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci USA 97(13):7533–7538
8. Markovska R, Boyanova L, Yordanov D, Gergova G, Mitov I (2011) Helicobacter pylori oipA genetic diversity and its associations with both disease and cagA, vacA s, m, and i alleles among Bulgarian patients. Diagn Microbiol Infect Dis 71(4):335–340
9. Ando T, Peek RM, Pride D, Levine SM, Takata T, Lee YC, Kusugami K, van der Ende A, Kuipers EJ, Kusters JG, Blaser MJ (2002) Polymorphisms of Helicobacter pylori HP0638 reflect geographic origin and correlate with cagA status. J Clin Microbiol 40(1):239–246
10. Delahay RM, Rugge M (2012) Pathogenesis of Helicobacter pylori infection. Helicobacter 17(Suppl 1):9–15
11. Palframan SL, Kwok T, Gabriel K (2012) Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis. Front Cell Infect Microbiol 2:92
12. Franco AT, Johnston E, Krishna U, Yamaoka Y, Israel DA, Nagy TA, Wroblewski LE, Piazuelo MB, Correa P, Peek RM Jr (2008) Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res 68(2):379–387
13. Dossumbekova A, Prinz C, Mages J, Lang R, Kusters JG, Van Vliet AH, Reindl W, Backert S, Saur D, Schmid RM, Rad R (2006) Helicobacter pylori HopH (OipA) and bacterial pathogenicity: genetic and functional genomic analysis of hopH gene polymorphisms. J Infect Dis 194(10):1346–1355
14. Graham DY, Opekun AR, Osato MS, El-Zimaity HM, Lee CK, Yamaoka Y, Qureshi WA, Cadoz M, Monath TP (2004) Challenge model for Helicobacter pylori infection in human volunteers. Gut 53(9):1235–1243
15. Liu J, He C, Chen M, Wang Z, Xing C, Yuan Y (2013) Association of presence/absence and on/off patterns of Helicobacter pylori oipA gene with peptic ulcer disease and gastric cancer risks: a meta-analysis. BMC Infect Dis 13:555
16. Yamaoka Y, Ojo O, Fujimoto S, Odenbreit S, Haas R, Gutierrez O, El-Zimaity HM, Reddy R, Arnqvist A, Graham DY (2006) Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut 55(6):775–781
17. Yamaoka Y (2010) Mechanisms of disease: helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol 7(11):629–641
18. Yamaoka Y, Kudo T, Lu H, Casola A, Brasier AR, Graham DY (2004) Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection. Gastroenterology 126(4):1030–1043
19. Yamaoka Y, Kita M, Kodama T, Imamura S, Ohno T, Sawai N, Ishimaru A, Imanishi J, Graham DY (2002) Helicobacter pylori infection in mice: role of outer membrane proteins in colonization and inflammation. Gastroenterology 123(6):1992–2004
20. Sakurai Y, Otani Y, Kameyama K, Hosoda Y, Okazaki I, Kubota T, Kumai K, Kitajima M (1997) Expression of interstitial collagenase (matrix metalloproteinase-1) in gastric cancers. Jpn J Cancer Res 88(4):401–406
21. Sugimoto M, Ohno T, Graham DY, Yamaoka Y (2009) Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbils. Cancer Sci 100(11):2152–2159
22. Odenbreit S, Kavermann H, Puls J, Haas R (2002) CagA tyrosine phosphorylation and interleukin-8 induction by Helicobacter pylori are independent from alpAB, HopZ and bab group outer membrane proteins. Int J Med Microbiol 292(3–4):257–266
23. Ando T, Peek RM Jr, Lee YC, Krishna U, Kusugami K, Blaser MJ (2002) Host cell responses to genotypically similar Helicobacter pylori isolates from United States and Japan. Clin Diagn Lab Immunol 9(1):167–175
24. Lee KS, Kalantzis A, Jackson CB, O’Connor L, Murata-Kamiya N, Hatakeyama M, Judd LM, Giraud AS, Menheniott TR (2012) Helicobacter pylori CagA triggers expression of the bactericidal lectin REG3gamma via gastric STAT3 activation. PLoS ONE 7(2):e30786
25. Pillinger MH, Marjanovic N, Kim SY, Lee YC, Scher JU, Roper J, Abeles AM, Izmirly PI, Axelrod M, Pillinger MY, Tolani S, Dinsell V, Abramson SB, Blaser MJ (2007) Helicobacter pylori stimulates gastric epithelial cell MMP-1 secretion via CagA-dependent and -independent ERK activation. J Biol Chem 282(26):18722–18731
26. Kwok T, Zabler D, Urman S, Rohde M, Hartig R, Wessler S, Misselwitz R, Berger J, Sewald N, Konig W, Backert S (2007) Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 449(7164):862–866
27. Yamaoka Y (2012) Pathogenesis of Helicobacter pylori-Related Gastroduodenal Diseases from Molecular Epidemiological Studies. Gastroenterol Res Pract 2012:371503
28. Lu H, Wu JY, Beswick EJ, Ohno T, Odenbreit S, Haas R, Reyes VE, Kita M, Graham DY, Yamaoka Y (2007) Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains. J Biol Chem 282(9):6242–6254
29. Choi IJ, Fujimoto S, Yamauchi K, Graham DY, Yamaoka Y (2007) Helicobacter pylori environmental interactions: effect of acidic conditions on H. pylori-induced gastric mucosal interleukin-8 production. Cell Microbiol 9(10):2457–2469
30. Baggiolini M (1998) Chemokines and leukocyte traffic. Nature 392(6676):565–568
31. Kudo T, Lu H, Wu JY, Graham DY, Casola A, Yamaoka Y (2005) Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori. Infect Immun 73(11):7602–7612
32. Lu H, Wu JY, Kudo T, Ohno T, Graham DY, Yamaoka Y (2005) Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol Biol Cell 16(10):4954–4966
33. Wu JY, Lu H, Sun Y, Graham DY, Cheung HS, Yamaoka Y (2006) Balance between polyoma enhancing activator 3 and activator protein 1 regulates Helicobacter pylori-stimulated matrix metalloproteinase 1 expression. Cancer Res 66(10):5111–5120
34. Tatsuguchi A, Fukuda Y, Ishizaki M, Yamanaka N (1999) Localization of matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in normal human and rabbit stomachs. Digestion 60(3):246–254
35. Gooz M, Gooz P, Smolka AJ (2001) Epithelial and bacterial metalloproteinases and their inhibitors in H. pylori infection of human gastric cells. Am J Physiol Gastrointest Liver Physiol 281(3):G823–G832
36. Janvier B, Grignon B, Audibert C, Pezennec L, Fauchere JL (1999) Phenotypic changes of Helicobacter pylori components during an experimental infection in mice. FEMS Immunol Med Microbiol 24(1):27–33
37. Small JV, Stradal T, Vignal E, Rottner K (2002) The lamellipodium: where motility begins. Trends Cell Biol 12(3):112–120
38. Schlaepfer DD, Hauck CR, Sieg DJ (1999) Signaling through focal adhesion kinase. Prog Biophys Mol Biol 71(3–4):435–478
39. Tabassam FH, Graham DY, Yamaoka Y (2008) OipA plays a role in Helicobacter pylori-induced focal adhesion kinase activation and cytoskeletal re-organization. Cell Microbiol 10(4):1008–1020
40. Deakin NO, Turner CE (2008) Paxillin comes of age. J Cell Sci 121(Pt 15):2435–2444
41. Brown MC, Turner CE (2004) Paxillin: adapting to change. Physiol Rev 84(4):1315–1339
42. Tabassam FH, Graham DY, Yamaoka Y (2011) Paxillin is a novel cellular target for converging Helicobacter pylori-induced cellular signaling. Am J Physiol Gastrointest Liver Physiol 301(4):G601–G611
43. Iwasaki T, Nakata A, Mukai M, Shinkai K, Yano H, Sabe H, Schaefer E, Tatsuta M, Tsujimura T, Terada N, Kakishita E, Akedo H (2002) Involvement of phosphorylation of Tyr-31 and Tyr-118 of paxillin in MM1 cancer cell migration. Int J Cancer 97(3):330–335
44. Franco AT, Israel DA, Washington MK, Krishna U, Fox JG, Rogers AB, Neish AS, Collier-Hyams L, Perez-Perez GI, Hatakeyama M, Whitehead R, Gaus K, O’Brien DP, Romero-Gallo J, Peek RM Jr (2005) Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci USA 102(30):10646–10651
45. Chen J, Lin M, Li N, Lin L, She F (2012) Therapeutic vaccination with Salmonella-delivered codon-optimized outer inflammatory protein DNA vaccine enhances protection in Helicobacter pylori infected mice. Vaccine 30(36):5310–5315
46. Chen J, Lin L, Li N, She F (2012) Enhancement of Helicobacter pylori outer inflammatory protein DNA vaccine efficacy by co-delivery of interleukin-2 and B subunit heat-labile toxin gene encoded plasmids. Microbiol Immunol 56(2):85–92
47. Li HB, Zhang JY, He YF, Chen L, Li B, Liu KY, Yang WC, Zhao Z, Zou QM, Wu C (2012) Systemic immunization with an epitope-based vaccine elicits a Th1-biased response and provides protection against Helicobacter pylori in mice. Vaccine 31(1):120–126
48. Kayhan B, Arasli M, Eren H, Aydemir S, Aktas E, Tekin I (2008) Analysis of peripheral blood lymphocyte phenotypes and Th1/Th2 cytokines profile in the systemic immune responses of Helicobacter pylori infected individuals. Microbiol Immunol 52(11):531–538
49. Wainberg ZA, Anghel A, Desai AJ, Ayala R, Luo T, Safran B, Fejzo MS, Hecht JR, Slamon DJ, Finn RS (2010) Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo. Clin Cancer Res 16(5):1509–1519
50. Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110(6):673–687